CFM Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

CFM Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-442	Closed	-$242K	–	172
2022 Q1	$242K	Hold	442	–	–	0.06%	167
2021 Q4	$278K	Hold	442	–	–	0.06%	152
2021 Q3	$274K	Hold	442	–	–	0.07%	151
2021 Q2	$279K	Hold	442	–	–	0.07%	140
2021 Q1	$216K	Sell	442 -35	-7%	-$17.5K	0.07%	162
2020 Q4	$238K	Buy	+477	New	+$213K	0.08%	142
2020 Q3	–	Sell	-486	Closed	-$160K	–	296
2020 Q2	$160K	Sell	486 -33	-6%	-$9.55K	0.06%	166
2020 Q1	$126K	Buy	+519	New	+$135K	0.06%	171

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CFM Wealth Partners's IDXX Position: Q2 2022 in Review

CFM Wealth Partners sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 442 shares — an estimated $242K sold.

CFM Wealth Partners first reported a position in IDXX in Q1 2020 and held it in 8 quarters. The position peaked at $279K in Q2 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

CFM Wealth Partners reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
CFM Wealth Partners sold 442 Idexx Laboratories shares in Q2 2022, an estimated $242K.
CFM Wealth Partners first reported a position in Idexx Laboratories in Q1 2020 and held it in 8 quarters.
CFM Wealth Partners's Idexx Laboratories position peaked at $279K in Q2 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on CFM Wealth Partners's 13F filing for Q2 2022, filed 12 Jul 2022.